GeneCellNano

Gene Cell Nano

GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.

Third ERC Grant for Professor Olli Ikkala12.4.2024
Save the Date for the Third Annual Meeting!7.12.2023
Professor Arto Urtti secures two major U.S. research grants9.11.2023
Professor Seppo Ylä-Herttuala receives the 2023 ESGCT Outstanding Achievement Award30.10.2023
Professor Tetsuya Terasaki receives esteemed Ariëns award29.9.2023

More News

Events

The 3rd Annual GCN Meeting 18.-19.4.202413.3.2024
EV4US & FISEV Annual meeting: extracellular vesicle research days in Oulu 5.-6.2.202415.1.2024
AIX Forum: collaborative meeting between GeneCellNano and the FCAI Flagship7.12.2023
Argumenta Healthy environment – healthy people workshop on extracellular vesicles 19.6.202315.6.2023
Research Seminar Afternoon of the CVD Research Community and the GeneCellNano Flagship 7.6.20231.6.2023

More Events

GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.

Gene Cell Nano

News

Events